BioXGEM.
KIDFamMap
Home
Example1
Example2
Statistics
Document
Contact US
Diseases
Inhibitor-Anchor Map
Family Anchors
Kinase-Inhibitor Family
Template
Protein
Surface
Ribbon
Inhibitor
ATP Location
Pocket
ATP
NLP
HAP
CLP
SP
3 FLT4 related diseases
H00535
Lymphedemas
602089
Hemangioma, capillary infantile, somatic
153100
Lymphedema, hereditary I
Summary of query kinase
Query kinase
FLT4 (
P35916
)
Kinase group
TK
Number of conformation types
0
Number of structural templates
65 (
Total 274 inhibitors
)
Number of FLT4 related diseases
3 (
H00535
602089
153100
)
Select
Template
Comformation
Type
No. of
Templates
Representative
Template
Kinase
Group
Representative
Inhibitor
Inhibitor
Type
No. of
Kinases
No. of
Inhibitors
No. of
Diseases
A
20
1SM2A_STU
(ITK)
TK
staurosporine
I
99
104
128
A
1SM2A_STU
(ITK)
TK
staurosporine
I
99
104
128
99
104
128
A
1SNUA_STU
(ITK)
TK
staurosporine
I
99
104
128
99
104
128
A
2HZ4A_4ST
(ABL1)
TK
staurosporine
I
159
103
156
159
103
156
A
2F4JA_VX6
(ABL1)
TK
VX-680
I
110
109
134
110
109
134
A
2RFNA_AM7
(MET)
TK
pyrimidone, 22
I
10
41
22
10
41
22
A
3GQLA_GQL
(FGFR1)
TK
HMS3401N17
I
14
14
58
14
14
58
A
2FGIA_PD1
(FGFR1)
TK
Pyrido[2,3-d...
I
24
157
70
24
157
70
A
3PJ1A_LHL
(BTK)
TK
AZD_1152HQPA
I
30
99
96
30
99
96
A
1AGWA_SU2
(FGFR1)
TK
SU 4984
I
77
81
111
77
81
111
A
3B8RA_887
(KDR)
TK
3b8r
II
4
32
7
4
32
7
A
3PJ3A_04L
(BTK)
TK
Imatinib
II
99
113
134
99
113
134
A
1FGIA_SU1
(FGFR1)
TK
Indolin-2-on...
I
25
71
61
25
71
61
A
1OPLA_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
3MJ1A_614
(ITK)
TK
7-(4-Methylp...
I
13
28
32
13
28
32
A
3EFKA_MT4
(MET)
TK
pyrimidone, 50
I
9
51
22
9
51
22
A
2FO0A_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
3OCSA_746
(BTK)
TK
CGI1746, 2
I
25
89
76
25
89
76
A
2G2HA_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
2HZIA_JIN
(ABL1)
TK
PD180970
I
90
77
120
90
77
120
A
3PIYA_585
(BTK)
TK
R-406
I
93
17
123
93
17
123
B
16
3BKBA_STU
(FES)
TK
staurosporine
I
131
107
138
B
3BKBA_STU
(FES)
TK
staurosporine
I
131
107
138
131
107
138
B
3CBLA_STU
(FES)
TK
staurosporine
I
131
107
138
131
107
138
B
3CD3A_STU
(FES)
TK
staurosporine
I
131
107
138
131
107
138
B
3LCSA_STU
(ALK)
TK
staurosporine
I
73
100
109
73
100
109
B
3F5PA_741
(IGF1R)
TK
3-cyanoquino...
I
60
123
81
60
123
81
B
2VWUA_7X1
(EPHB4)
TK
Chlorobenzod...
I
77
287
111
77
287
111
B
2WKMA_PFY
(MET)
TK
PHA-665752
I
38
34
98
38
34
98
B
2X9FA_X9F
(EPHB4)
TK
X9F
I
46
19
86
46
19
86
B
3AOXA_EMH
(ALK)
TK
BIRB_796
I
34
28
85
34
28
85
B
3LVPA_PDR
(IGF1R)
TK
DNC009399
I
18
59
52
18
59
52
B
3EKNA_GS3
(INSR)
TK
pyrrolo[2,3-...
I
90
215
127
90
215
127
B
3LW0A_CCX
(IGF1R)
TK
5-vinyl-3-py...
III
53
30
101
53
30
101
B
2XB7A_GUI
(ALK)
TK
NVP-TAE684
I
71
66
107
71
66
107
B
3EKKA_GS2
(INSR)
TK
pyrrolo[2,3-...
I
33
131
65
33
131
65
B
3RHKA_M97
(MET)
TK
bisindolylma...
I
5
10
23
5
10
23
B
2OJ9A_BMI
(IGF1R)
TK
BMI
I
10
75
37
10
75
37
D
3
1R0PA_KSA
(MET)
TK
k-252a
I
28
79
64
D
1R0PA_KSA
(MET)
TK
k-252a
I
28
79
64
28
79
64
D
3DKFA_SX8
(MET)
TK
1-{[6-(pyrid...
I
3
5
11
3
5
11
D
3DKGA_SX8
(MET)
TK
1-{[6-(pyrid...
I
3
5
11
3
5
11
E
24
3C7QA_XIN
(KDR)
TK
BIBF1120
I
25
56
50
E
3C7QA_XIN
(KDR)
TK
BIBF1120
I
25
56
50
25
56
50
E
3G0FA_B49
(KIT)
TK
Sunitinib
I
37
40
78
37
40
78
E
3G0EA_B49
(KIT)
TK
Sunitinib
I
37
40
78
37
40
78
E
3HNGA_8ST
(FLT1)
TK
HMS3229O07
II
10
91
21
10
91
21
E
2P2IA_608
(KDR)
TK
nicotinamide...
II
15
58
45
15
58
45
E
3EFLA_706
(KDR)
TK
Motesanib
II
15
69
43
15
69
43
E
3KRLA_KRL
(CSF1R)
TK
5-Cyano-N-[4...
I
11
88
23
11
88
23
E
3QRJA_919
(ABL1)
TK
Sorafenib
II
23
18
54
23
18
54
E
2OFVA_242
(LCK)
TK
2ofv
II
28
181
65
28
181
65
E
1UWHA_BAX
(BRAF)
TK
Sorafenib
II
19
39
35
19
39
35
E
1UWJA_BAX
(BRAF)
TK
Sorafenib
II
19
39
35
19
39
35
E
2OG8A_1N8
(LCK)
TK
1N8
II
35
190
69
35
190
69
E
3Q96A_0NF
(BRAF)
TK
(2s)-N-[3-(2...
II
19
21
35
19
21
35
E
3QRIA_919
(ABL1)
TK
Sorafenib
II
23
18
54
23
18
54
E
3FZSA_B96
(PTK2B)
TK
Doramapimod
II
4
23
11
4
23
11
E
1YWNA_LIF
(KDR)
TK
AC1NS1DP
II
17
49
42
17
49
42
E
3EWHA_K11
(KDR)
TK
k11
II
17
27
46
17
27
46
E
3DPKA_8C5
(CSF1R)
TK
Pyrido[2,3-d...
I
7
57
17
7
57
17
E
3CPBA_C92
(KDR)
TK
3cpb
II
12
86
32
12
86
32
E
3C1XA_CKK
(MET)
TK
AZD_1152HQPA
II
19
77
36
19
77
36
E
3LQ8A_88Z
(MET)
TK
AZD_1152HQPA
II
19
71
36
19
71
36
E
3BYSA_AM5
(LCK)
TK
Aminopyrimid...
II
20
220
65
20
220
65
E
3KRJA_KRJ
(CSF1R)
TK
AMG_706
I
11
49
23
11
49
23
E
3BYUA_AM6
(LCK)
TK
Aminopyrimid...
II
19
186
61
19
186
61
F
2
3FZTA_4JZ
(PTK2B)
TK
PF-4618433
II
9
20
24
F
3FZTA_4JZ
(PTK2B)
TK
PF-4618433
II
9
20
24
9
20
24
F
2RL5A_2RL
(KDR)
TK
Sorafenib
II
12
94
45
12
94
45